Table 5.
Patient characteristics of the no sarcopenia and sarcopenia groups after propensity score matching.
| Characteristics | Type of Participants | p-value | |
|---|---|---|---|
| No sarcopenia (n=44); N (%) | Sarcopenia (n=44); N (%) | ||
| Age group | 0.478 | ||
| <65 | 30 (68.2) | 33 (75.0) | |
| ≥65 | 14 (31.8) | 11 (25.0) | |
| Gender | 0.381 | ||
| Female | 19 (43.2) | 15 (34.1) | |
| Male | 25 (56.8) | 29 (65.9) | |
| Smoking | 0.828 | ||
| No | 26 (59.1) | 27 (61.4) | |
| Yes | 18 (40.9) | 17 (38.6) | |
| ICI type | 0.777 | ||
| PD-1 | 36 (81.8) | 37 (84.1) | |
| PD-L1 | 8 (18. 2) | 7 (15.9) | |
| BMI | 0.520 | ||
| Underweight | 2 (4.5) | 3 (6.8) | |
| Normal weight | 27 (61.4) | 26 (59.1) | |
| Overweight and Obese | 15 (34.1) | 15 (34.1) | |
| Performance status | 0.694 | ||
| 0 | 6 (13.6) | 9 (20.5) | |
| 1 | 17 (38.6) | 16 (36.4) | |
| 2 | 21 (47.7) | 18 (43.2) | |
| Histology | 0.670 | ||
| Adenocarcinoma | 24 (54.5) | 19 (43.2) | |
| Squamous | 12 (27.3) | 13 (29.5) | |
| Neuroendocrine | 8 (18.2) | 12 (27.3) | |
| Line of PD-1/PD-L1 therapy | 0.758 | ||
| First | 36 (81.8) | 35 (79.5) | |
| Second or above | 8 (18.2) | 9 (20.5) | |
| PD-L1 expression | |||
| <1% | 22 (50.0) | 21 (47.7) | 0.831 |
| ≥ 1% | 22 (50.0) | 23 (52.3) | |
| Nutritional status | 0.533 | ||
| Well nourished | 15 (34.1) | 15 (34.1) | |
| Moderate or suspected malnutrition | 20 (45.5) | 22 (50.0) | |
| Severe malnutrition | 9 (20.5) | 7 (15.9) | |